NICE recommends "targeted" drug capivasertib for advanced breast cancer
BMJ
.
2025 Apr 14:389:r762.
doi: 10.1136/bmj.r762.
Author
Adrian O'Dowd
1
Affiliation
1
London.
PMID:
40228825
DOI:
10.1136/bmj.r762
No abstract available